All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Not reported | 2005-003813-33 | Effects of Adrenaline on gastric tube blood flow in patients having thoracic epidural for Oesophagogastrectomy | 2007-03-26 | due-trials |
Other | 2009-011175-70 | A randomised factorial trial of N-acetylcysteine prophylaxis and iso-osmolar versus low-osmolar contrast media on kidney function in patients at risk of contrast induced nephropathy following cardiac ... | not-yet-due | |
Reported results | 2009-015800-25 | A pilot randomised control trial, in intensive care patients, comparing seven days versus two days treatment with empirical antibiotics to treat hospital acquired infection of unknown origin | 2011-07-31 | due-trials |
Not reported | 2011-005273-23 | HEAT-PPCI - How Effective are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention - A randomised controlled trial to compare unfractionated heparin versus bivalirudin in the treatme... | 2018-12-17 | due-trials |
Other | 2012-002880-86 | PRESERVING ΒETA-CELLS: ‘RESTING THE PANCREAS’ IN CYSTIC FIBROSIS | not-yet-due | |
Not reported Terminated | 2013-001447-31 | A randomised controlled trial to study the effect of acetazolamide on the incidence of blood-stained CSF, effect on cerebrospinal fluid (CSF) pressure, CSF drainage and neurological dysfunction in pat... | 2018-03-07 | due-trials |
Other | 2015-003260-37 | Can Ivabradine attenuate post-revascularisation microcirculatory dysfunction in flow limiting coronary artery disease? | not-yet-due | |
Reported results | 2016-002832-34 | Aztreonam for inhalation for the treatment of acute exacerbations in cystic fibrosis. An open-label, randomised, cross-over pilot study of AZLI plus intravenous Colistin versus standard dual intraveno... | 2019-09-27 | due-trials |